These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9135704)

  • 1. Effect of low dose oxandrolone and testosterone treatment on the pituitary-testicular and GH axes in boys with constitutional delay of growth and puberty.
    Crowne EC; Wallace WH; Moore C; Mitchell R; Robertson WH; Holly JM; Shalet SM
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):209-16. PubMed ID: 9135704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degree of activation of the pituitary-testicular axis in early pubertal boys with constitutional delay of growth and puberty determines the growth response to treatment with testosterone or oxandrolone.
    Crowne EC; Wallace WH; Moore C; Mitchell R; Robertson WR; Shalet SM
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1869-75. PubMed ID: 7775634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of oxandrolone on the growth hormone and gonadal axes in boys with constitutional delay of growth and puberty.
    Malhotra A; Poon E; Tse WY; Pringle PJ; Hindmarsh PC; Brook CG
    Clin Endocrinol (Oxf); 1993 Apr; 38(4):393-8. PubMed ID: 8319371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxandrolone induces a sustained rise in physiological growth hormone secretion in boys with constitutional delay of growth and puberty.
    Stanhope R; Hindmarsh P; Pringle PJ; Holownia P; Honour J; Brook CG
    Pediatrician; 1987; 14(3):183-8. PubMed ID: 3453497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early morning plasma testosterone is an accurate predictor of imminent pubertal development in prepubertal boys.
    Wu FC; Brown DC; Butler GE; Stirling HF; Kelnar CJ
    J Clin Endocrinol Metab; 1993 Jan; 76(1):26-31. PubMed ID: 8421096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth and growth hormone responses to oxandrolone in boys with constitutional delay of growth and puberty (CDGP).
    Clayton PE; Shalet SM; Price DA; Addison GM
    Clin Endocrinol (Oxf); 1988 Aug; 29(2):123-30. PubMed ID: 3248354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral treatment for constitutional delay of growth and puberty in boys: a randomised trial of an anabolic steroid or testosterone undecanoate.
    Albanese A; Kewley GD; Long A; Pearl KN; Robins DG; Stanhope R
    Arch Dis Child; 1994 Oct; 71(4):315-7. PubMed ID: 7979523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study.
    Juul A; Andersson AM; Pedersen SA; Jørgensen JO; Christiansen JS; Groome NP; Skakkebaek NE
    Horm Res; 1998; 49(6):269-78. PubMed ID: 9623518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double blind placebo controlled trial of low dose oxandrolone in the treatment of boys with constitutional delay of growth and puberty.
    Stanhope R; Buchanan CR; Fenn GC; Preece MA
    Arch Dis Child; 1988 May; 63(5):501-5. PubMed ID: 3389864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen therapy in constitutional delay of growth.
    Lampit M; Hochberg Z
    Horm Res; 2003; 59(6):270-5. PubMed ID: 12784090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxandrolone therapy in constitutionally delayed growth and puberty. Bio-Technology General Corporation Cooperative Study Group.
    Wilson DM; McCauley E; Brown DR; Dudley R
    Pediatrics; 1995 Dec; 96(6):1095-100. PubMed ID: 7491227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature.
    Salehpour S; Alipour P; Razzaghy-Azar M; Ardeshirpour L; Shamshiri A; Monfared MF; Gharib A
    Horm Res Paediatr; 2010; 74(6):428-35. PubMed ID: 20628237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of prolonged administration of an anabolic steroid (oxandrolone) on growth in boys with constitutionally delayed growth and puberty.
    Schroor EJ; van Weissenbruch MM; Knibbe P; Delemarre-van de Waal HA
    Eur J Pediatr; 1995 Dec; 154(12):953-7. PubMed ID: 8801102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of growth hormone secretion after testosterone treatment in boys with constitutional delay of growth and adolescence: evidence against an increase in hypothalamic secretion of growth hormone-releasing hormone.
    Racine MS; Symons KV; Foster CM; Barkan AL
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3326-31. PubMed ID: 15240610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin, insulin-like growth factor-binding protein-1, and sex hormone-binding globulin in patients with Turner's syndrome: course over age in untreated patients and effect of therapy with growth hormone alone and in combination with oxandrolone.
    Haeusler G; Schmitt K; Blümel P; Plöchl E; Waldhör T; Frisch H
    J Clin Endocrinol Metab; 1996 Feb; 81(2):536-41. PubMed ID: 8636264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxandrolone in low dose for constitutional delay of growth and puberty in boys.
    Stanhope R; Brook CG
    Arch Dis Child; 1985 Apr; 60(4):379-81. PubMed ID: 4004317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Müllerian hormone and letrozole levels in boys with constitutional delay of growth and puberty treated with letrozole or testosterone.
    Kohva E; Varimo T; Huopio H; Tenhola S; Voutilainen R; Toppari J; Miettinen PJ; Vaaralahti K; Viinamäki J; Backman JT; Hero M; Raivio T
    Hum Reprod; 2020 Feb; 35(2):257-264. PubMed ID: 31958337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of the short stature due to pubertal delay in boys.
    Adan L; Souberbielle JC; Brauner R
    J Clin Endocrinol Metab; 1994 Feb; 78(2):478-82. PubMed ID: 7508951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of growth hormone monotherapy and growth hormone in combination with oxandrolone or testosterone on thyroxid hormone parameters and thyroxine binding globulin in patients with Ullrich-Turner syndrome.
    Schmitt K; Häusler G; Blümel P; Plöchl E; Waldhör T; Frisch H
    Eur J Pediatr; 1997 Feb; 156(2):99-103. PubMed ID: 9039510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of changing gonadotropin-releasing hormone pulse frequency on puberty.
    Bridges NA; Hindmarsh PC; Matthews DR; Brook CG
    J Clin Endocrinol Metab; 1994 Sep; 79(3):841-7. PubMed ID: 8077371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.